Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI.
Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, Beaulieu AD, Abram F, Dorais M, Vignon E, Pelletier JP; Canadian Licofelone Study Group. Raynauld JP, et al. Among authors: dorais m. Ann Rheum Dis. 2009 Jun;68(6):938-47. doi: 10.1136/ard.2008.088732. Epub 2008 Jul 23. Ann Rheum Dis. 2009. PMID: 18653484 Clinical Trial.
Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis.
Raynauld JP, Martel-Pelletier J, Abram F, Dorais M, Haraoui B, Choquette D, Bias P, Emmert KH, Laufer S, Pelletier JP. Raynauld JP, et al. Among authors: dorais m. Arthritis Res Ther. 2008;10(6):R129. doi: 10.1186/ar2543. Epub 2008 Nov 5. Arthritis Res Ther. 2008. PMID: 18986534 Free PMC article. Clinical Trial.
Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis.
Pelletier JP, Raynauld JP, Caron J, Mineau F, Abram F, Dorais M, Haraoui B, Choquette D, Martel-Pelletier J. Pelletier JP, et al. Among authors: dorais m. Ann Rheum Dis. 2010 Dec;69(12):2095-101. doi: 10.1136/ard.2009.122002. Epub 2010 Jun 22. Ann Rheum Dis. 2010. PMID: 20570834 Clinical Trial.
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI.
Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M, Pelletier JP. Wildi LM, et al. Among authors: dorais m. Ann Rheum Dis. 2011 Jun;70(6):982-9. doi: 10.1136/ard.2010.140848. Epub 2011 Mar 1. Ann Rheum Dis. 2011. PMID: 21367761 Free PMC article. Clinical Trial.
Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation.
Raynauld JP, Martel-Pelletier J, Haraoui B, Choquette D, Dorais M, Wildi LM, Abram F, Pelletier JP; Canadian Licofelone Study Group. Raynauld JP, et al. Among authors: dorais m. Ann Rheum Dis. 2011 Aug;70(8):1382-8. doi: 10.1136/ard.2010.146407. Epub 2011 May 8. Ann Rheum Dis. 2011. PMID: 21551506 Clinical Trial.
Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss.
Pelletier JP, Roubille C, Raynauld JP, Abram F, Dorais M, Delorme P, Martel-Pelletier J. Pelletier JP, et al. Among authors: dorais m. Ann Rheum Dis. 2015 Feb;74(2):422-9. doi: 10.1136/annrheumdis-2013-203989. Epub 2013 Dec 2. Ann Rheum Dis. 2015. PMID: 24297379 Clinical Trial.
123 results